[1]
2024. IMMUNOPHENOTYPING OF BIOLOGICAL MATERIAL TO IDENTIFY HEMOBLASTOSIS MARKERS IN BLAST CRISIS FOR SELECTING ADEQUATE POLYCHEMOTHERAPY IN HEMOBLASTOSIS. International journal of artificial intelligence. 4, 07 (Oct. 2024), 363–367.